The trial is the first in the United States to offer an FDA-approved adipose-derived stem cell trial for shoulder injuries. The trial opened in Fargo, North Dakota, and Sioux Falls in December 2016. In this trial, one's own adipose stem cells are used to determine if they can repair partial thickness rotator cuff tears.
A new study attributes a surge in dislocated knees to the U.S. obesity epidemic.
Except for increased anterior-posterior knee laxity, results from this study indicated female athletes and male athletes were not similar with regard to predictors for first-time noncontact ACL injury.
Most patients who underwent nonoperative treatment for rotator cuff tears had anatomic tear deterioration, with poorer functional outcomes found in large tear size increases and progression of muscle atrophy, according to results.
According to a new study, the type of procedure used to treat shoulder calcifications should be tailored to the type of calcification.
